We describe a 39-year-old male patient who developed bleomycin-induced 
pneumonitis 2 years after completion of chemotherapy for nonseminomatous 
testicular cancer. Bleomycin sometimes causes fatal pulmonary toxicity, 
including bleomycin-induced pneumonitis. The central event in the development of 
pneumonitis is endothelial damage of the lung vasculature due to 
bleomycin-induced cytokines and free radicals. Pulmonary toxicity usually begins 
at bleomycin administration. The development of bleomycin-induced pneumonitis up 
to 6 months after bleomycin therapy has also been reported. We report a patient 
who developed bleomycin-induced pneumonitis 2 years after the initiation of 
bleomycin-containing chemotherapy regimens.